Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Liver Transplantation | 8 | 2024 | 2330 | 1.400 |
Why?
|
Sepsis | 18 | 2015 | 2585 | 1.350 |
Why?
|
Myeloid Cells | 4 | 2014 | 823 | 0.940 |
Why?
|
End Stage Liver Disease | 2 | 2020 | 352 | 0.930 |
Why?
|
Splenorenal Shunt, Surgical | 1 | 2022 | 14 | 0.810 |
Why?
|
Choledochal Cyst | 1 | 2022 | 25 | 0.790 |
Why?
|
Pancreas Transplantation | 2 | 2022 | 197 | 0.780 |
Why?
|
Alagille Syndrome | 1 | 2021 | 45 | 0.770 |
Why?
|
Hypertension, Renovascular | 1 | 2021 | 116 | 0.750 |
Why?
|
Gallbladder | 1 | 2022 | 308 | 0.700 |
Why?
|
Esophageal and Gastric Varices | 1 | 2022 | 208 | 0.670 |
Why?
|
Immunity, Innate | 10 | 2015 | 3066 | 0.670 |
Why?
|
Hypertension, Portal | 1 | 2022 | 226 | 0.670 |
Why?
|
Hematoma, Subdural | 1 | 2020 | 127 | 0.640 |
Why?
|
Wounds and Injuries | 7 | 2013 | 2492 | 0.590 |
Why?
|
Myelopoiesis | 3 | 2015 | 134 | 0.580 |
Why?
|
Chemokine CXCL10 | 4 | 2014 | 316 | 0.550 |
Why?
|
Adaptor Proteins, Vesicular Transport | 3 | 2014 | 305 | 0.550 |
Why?
|
Bacterial Infections | 3 | 2013 | 1391 | 0.490 |
Why?
|
Meconium | 2 | 2012 | 47 | 0.480 |
Why?
|
Immune Tolerance | 7 | 2014 | 2302 | 0.470 |
Why?
|
Enema | 2 | 2012 | 141 | 0.460 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2020 | 783 | 0.440 |
Why?
|
Cecum | 5 | 2014 | 233 | 0.430 |
Why?
|
Toll-Like Receptors | 2 | 2014 | 589 | 0.420 |
Why?
|
Leukocytes | 9 | 2014 | 2026 | 0.420 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2014 | 238 | 0.420 |
Why?
|
Wounds, Nonpenetrating | 6 | 2015 | 807 | 0.410 |
Why?
|
Suppressor Factors, Immunologic | 1 | 2012 | 68 | 0.410 |
Why?
|
Cachexia | 1 | 2014 | 202 | 0.410 |
Why?
|
Venous Thrombosis | 1 | 2022 | 1303 | 0.400 |
Why?
|
Ileal Diseases | 1 | 2012 | 68 | 0.390 |
Why?
|
Barium Sulfate | 1 | 2012 | 180 | 0.380 |
Why?
|
Upper Gastrointestinal Tract | 1 | 2011 | 46 | 0.370 |
Why?
|
Fundoplication | 1 | 2011 | 144 | 0.350 |
Why?
|
Receptors, CXCR3 | 1 | 2011 | 238 | 0.340 |
Why?
|
Neoplasms, Experimental | 1 | 2014 | 1229 | 0.320 |
Why?
|
Waiting Lists | 2 | 2024 | 765 | 0.310 |
Why?
|
Trauma Centers | 2 | 2014 | 937 | 0.310 |
Why?
|
Gastrostomy | 1 | 2011 | 323 | 0.310 |
Why?
|
Intestinal Obstruction | 1 | 2012 | 432 | 0.300 |
Why?
|
Myeloproliferative Disorders | 1 | 2014 | 613 | 0.300 |
Why?
|
Horses | 1 | 2009 | 300 | 0.300 |
Why?
|
Pulmonary Surgical Procedures | 1 | 2008 | 34 | 0.300 |
Why?
|
Thrombosis | 1 | 2022 | 2942 | 0.300 |
Why?
|
Kidney Neoplasms | 2 | 2020 | 4251 | 0.290 |
Why?
|
Pancreas | 2 | 2012 | 1691 | 0.280 |
Why?
|
Animals, Newborn | 5 | 2015 | 2677 | 0.260 |
Why?
|
Signal Transduction | 9 | 2014 | 23447 | 0.250 |
Why?
|
Cause of Death | 2 | 2013 | 3683 | 0.250 |
Why?
|
Cystic Fibrosis | 3 | 2012 | 1285 | 0.250 |
Why?
|
Cytokines | 8 | 2014 | 7396 | 0.240 |
Why?
|
Hematopoietic Stem Cells | 3 | 2015 | 3397 | 0.240 |
Why?
|
Gastroesophageal Reflux | 1 | 2011 | 819 | 0.220 |
Why?
|
Clonal Anergy | 1 | 2003 | 169 | 0.210 |
Why?
|
Hepatoblastoma | 1 | 2023 | 90 | 0.210 |
Why?
|
Preoperative Care | 2 | 2011 | 2242 | 0.210 |
Why?
|
Mice | 26 | 2023 | 81539 | 0.210 |
Why?
|
Lymphocyte Activation | 3 | 2010 | 5485 | 0.200 |
Why?
|
Disease Models, Animal | 10 | 2015 | 18255 | 0.200 |
Why?
|
Portasystemic Shunt, Surgical | 1 | 2022 | 39 | 0.200 |
Why?
|
Phagocytosis | 5 | 2015 | 1528 | 0.190 |
Why?
|
Child | 13 | 2024 | 80158 | 0.190 |
Why?
|
CD4-Positive T-Lymphocytes | 6 | 2013 | 4369 | 0.190 |
Why?
|
Shock, Hemorrhagic | 2 | 2013 | 223 | 0.190 |
Why?
|
Granulocytes | 2 | 2014 | 551 | 0.190 |
Why?
|
Nanotechnology | 1 | 2006 | 714 | 0.180 |
Why?
|
Neutrophils | 7 | 2015 | 3767 | 0.180 |
Why?
|
APACHE | 4 | 2013 | 267 | 0.180 |
Why?
|
Melanoma, Experimental | 1 | 2003 | 561 | 0.180 |
Why?
|
Genomics | 2 | 2013 | 5821 | 0.180 |
Why?
|
BK Virus | 1 | 2020 | 123 | 0.170 |
Why?
|
Animals | 29 | 2023 | 168475 | 0.160 |
Why?
|
Portal Vein | 1 | 2022 | 431 | 0.160 |
Why?
|
Erythrocyte Transfusion | 2 | 2015 | 570 | 0.160 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 2022 | 506 | 0.160 |
Why?
|
Gastric Mucosa | 1 | 2022 | 604 | 0.160 |
Why?
|
Athletic Injuries | 1 | 2009 | 1216 | 0.160 |
Why?
|
Antigens, Neoplasm | 2 | 2003 | 1993 | 0.160 |
Why?
|
Interferon Type I | 2 | 2014 | 562 | 0.150 |
Why?
|
Mice, Knockout | 8 | 2015 | 14417 | 0.150 |
Why?
|
Polyomavirus Infections | 1 | 2020 | 194 | 0.150 |
Why?
|
Humans | 45 | 2024 | 761596 | 0.150 |
Why?
|
Neutrophil Infiltration | 2 | 2011 | 390 | 0.150 |
Why?
|
Mice, Inbred C57BL | 13 | 2023 | 22174 | 0.150 |
Why?
|
Constriction, Pathologic | 1 | 2021 | 1096 | 0.150 |
Why?
|
Tumor Virus Infections | 1 | 2020 | 438 | 0.140 |
Why?
|
Macrophages, Peritoneal | 2 | 2015 | 238 | 0.140 |
Why?
|
Kidney Transplantation | 2 | 2024 | 4235 | 0.140 |
Why?
|
Clostridium Infections | 2 | 2015 | 558 | 0.140 |
Why?
|
Toll-Like Receptor 4 | 2 | 2011 | 579 | 0.140 |
Why?
|
Ligation | 4 | 2010 | 448 | 0.130 |
Why?
|
Tissue and Organ Procurement | 1 | 2024 | 962 | 0.130 |
Why?
|
Abdomen | 1 | 2022 | 1128 | 0.130 |
Why?
|
Injury Severity Score | 3 | 2014 | 1045 | 0.130 |
Why?
|
Multiple Organ Failure | 3 | 2012 | 387 | 0.130 |
Why?
|
Tissue Donors | 2 | 2022 | 2332 | 0.120 |
Why?
|
Respiratory Insufficiency | 1 | 2024 | 1230 | 0.120 |
Why?
|
Mice, Inbred BALB C | 5 | 2014 | 6214 | 0.120 |
Why?
|
Male | 30 | 2024 | 360846 | 0.120 |
Why?
|
Child, Preschool | 6 | 2024 | 42232 | 0.120 |
Why?
|
Genome-Wide Association Study | 2 | 2014 | 12690 | 0.120 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2022 | 1116 | 0.120 |
Why?
|
Caspase 1 | 1 | 2015 | 225 | 0.120 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2023 | 4580 | 0.120 |
Why?
|
Reoperation | 2 | 2024 | 4303 | 0.120 |
Why?
|
Monocytes | 1 | 2023 | 2570 | 0.110 |
Why?
|
Lung Diseases | 1 | 2024 | 1909 | 0.110 |
Why?
|
Chemokines | 2 | 2014 | 959 | 0.110 |
Why?
|
Omentum | 1 | 2014 | 168 | 0.110 |
Why?
|
Muscle Neoplasms | 1 | 2014 | 130 | 0.110 |
Why?
|
Gene Expression Regulation | 5 | 2014 | 11904 | 0.110 |
Why?
|
Female | 26 | 2024 | 392705 | 0.110 |
Why?
|
Living Donors | 1 | 2017 | 641 | 0.100 |
Why?
|
Burns | 3 | 2013 | 1882 | 0.100 |
Why?
|
Myeloid Differentiation Factor 88 | 2 | 2014 | 587 | 0.100 |
Why?
|
Punctures | 2 | 2010 | 366 | 0.100 |
Why?
|
Sacrum | 1 | 2014 | 276 | 0.100 |
Why?
|
Transplantation, Homologous | 2 | 2020 | 4807 | 0.100 |
Why?
|
Lactoferrin | 1 | 2013 | 100 | 0.100 |
Why?
|
Syndrome | 2 | 2024 | 3267 | 0.100 |
Why?
|
Micelles | 1 | 2012 | 192 | 0.100 |
Why?
|
Caspases | 1 | 2015 | 879 | 0.100 |
Why?
|
Soybean Oil | 1 | 2012 | 139 | 0.100 |
Why?
|
Calcitonin | 1 | 2013 | 329 | 0.100 |
Why?
|
Plasma | 1 | 2015 | 586 | 0.100 |
Why?
|
Florida | 2 | 2013 | 431 | 0.100 |
Why?
|
Hepatitis C, Chronic | 1 | 2020 | 1032 | 0.100 |
Why?
|
Inflammation | 5 | 2015 | 10774 | 0.100 |
Why?
|
Inflammasomes | 2 | 2015 | 526 | 0.090 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2023 | 2297 | 0.090 |
Why?
|
Critical Care | 2 | 2015 | 2697 | 0.090 |
Why?
|
Retrospective Studies | 11 | 2024 | 80647 | 0.090 |
Why?
|
Acute Kidney Injury | 2 | 2013 | 1924 | 0.090 |
Why?
|
Antimicrobial Cationic Peptides | 1 | 2013 | 353 | 0.090 |
Why?
|
Surgical Procedures, Operative | 2 | 2012 | 1924 | 0.090 |
Why?
|
Wound Infection | 1 | 2013 | 246 | 0.090 |
Why?
|
Multiple Trauma | 1 | 2013 | 369 | 0.090 |
Why?
|
Hospital Mortality | 3 | 2013 | 5293 | 0.090 |
Why?
|
Hirschsprung Disease | 1 | 2012 | 163 | 0.090 |
Why?
|
Immunosuppressive Agents | 1 | 2023 | 4176 | 0.090 |
Why?
|
Reactive Oxygen Species | 2 | 2014 | 2139 | 0.080 |
Why?
|
Fat Emulsions, Intravenous | 1 | 2012 | 314 | 0.080 |
Why?
|
Infant, Newborn | 5 | 2014 | 26202 | 0.080 |
Why?
|
Kidney | 2 | 2023 | 7048 | 0.080 |
Why?
|
Hepatitis C | 1 | 2020 | 1584 | 0.080 |
Why?
|
Bone Marrow Cells | 4 | 2011 | 2417 | 0.080 |
Why?
|
Ileus | 1 | 2009 | 66 | 0.080 |
Why?
|
Lectins, C-Type | 1 | 2013 | 585 | 0.080 |
Why?
|
Perioperative Care | 1 | 2017 | 1036 | 0.080 |
Why?
|
Chemokine CXCL12 | 1 | 2011 | 454 | 0.080 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2011 | 755 | 0.080 |
Why?
|
Postoperative Complications | 3 | 2024 | 15633 | 0.080 |
Why?
|
Protein Precursors | 1 | 2013 | 1132 | 0.080 |
Why?
|
Gastric Emptying | 1 | 2011 | 242 | 0.080 |
Why?
|
Protective Clothing | 1 | 2009 | 103 | 0.080 |
Why?
|
Carcinoma, Renal Cell | 1 | 2003 | 3165 | 0.080 |
Why?
|
Peritonitis | 1 | 2010 | 368 | 0.080 |
Why?
|
Models, Immunological | 1 | 2010 | 513 | 0.080 |
Why?
|
Cell Proliferation | 3 | 2014 | 10451 | 0.080 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2013 | 858 | 0.080 |
Why?
|
Survival Analysis | 4 | 2014 | 10090 | 0.080 |
Why?
|
Immunity | 1 | 2014 | 996 | 0.070 |
Why?
|
Disease Susceptibility | 1 | 2014 | 1787 | 0.070 |
Why?
|
Acute Lung Injury | 1 | 2011 | 367 | 0.070 |
Why?
|
Liver Neoplasms | 1 | 2023 | 4317 | 0.070 |
Why?
|
Unnecessary Procedures | 1 | 2011 | 415 | 0.070 |
Why?
|
Blood Proteins | 1 | 2013 | 1173 | 0.070 |
Why?
|
Antigen-Presenting Cells | 4 | 2005 | 964 | 0.070 |
Why?
|
Lymphoma, B-Cell | 2 | 2005 | 940 | 0.070 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2012 | 621 | 0.070 |
Why?
|
Cross Infection | 2 | 2013 | 1422 | 0.070 |
Why?
|
Infant | 3 | 2024 | 36193 | 0.070 |
Why?
|
Virus Diseases | 1 | 2013 | 718 | 0.070 |
Why?
|
Health Services Accessibility | 1 | 2024 | 5440 | 0.070 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2011 | 2496 | 0.070 |
Why?
|
Flow Cytometry | 3 | 2011 | 5870 | 0.070 |
Why?
|
Nanotubes, Carbon | 1 | 2006 | 71 | 0.060 |
Why?
|
Interleukin-6 | 2 | 2013 | 3208 | 0.060 |
Why?
|
Benchmarking | 1 | 2012 | 1045 | 0.060 |
Why?
|
Cell Adhesion Molecules | 1 | 2011 | 1601 | 0.060 |
Why?
|
Patient Selection | 1 | 2017 | 4244 | 0.060 |
Why?
|
Brain Injuries | 2 | 2015 | 2054 | 0.060 |
Why?
|
Graft Rejection | 3 | 2024 | 4446 | 0.060 |
Why?
|
Liver Diseases | 1 | 2013 | 1297 | 0.060 |
Why?
|
Artifacts | 1 | 2013 | 1911 | 0.060 |
Why?
|
Mice, SCID | 3 | 2005 | 2626 | 0.060 |
Why?
|
Cells, Cultured | 3 | 2014 | 18966 | 0.060 |
Why?
|
Bacteremia | 1 | 2010 | 980 | 0.060 |
Why?
|
Genetic Predisposition to Disease | 3 | 2014 | 17904 | 0.050 |
Why?
|
Primary Graft Dysfunction | 1 | 2024 | 111 | 0.050 |
Why?
|
Graft Survival | 2 | 2024 | 3820 | 0.050 |
Why?
|
Time Factors | 5 | 2023 | 39969 | 0.050 |
Why?
|
Adaptive Immunity | 3 | 2014 | 726 | 0.050 |
Why?
|
Escherichia coli | 1 | 2014 | 4217 | 0.050 |
Why?
|
Mice, Inbred DBA | 1 | 2023 | 621 | 0.050 |
Why?
|
Treatment Outcome | 4 | 2023 | 64685 | 0.050 |
Why?
|
Bone Neoplasms | 1 | 2014 | 2529 | 0.050 |
Why?
|
Ischemia | 1 | 2010 | 1884 | 0.050 |
Why?
|
Nanostructures | 1 | 2006 | 552 | 0.050 |
Why?
|
Oxygen | 1 | 2012 | 4227 | 0.050 |
Why?
|
Sensitivity and Specificity | 2 | 2013 | 14665 | 0.050 |
Why?
|
Adolescent | 6 | 2024 | 88326 | 0.050 |
Why?
|
Antigens, CD | 1 | 2011 | 4001 | 0.050 |
Why?
|
Antigen Presentation | 2 | 2003 | 1251 | 0.050 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2014 | 3779 | 0.050 |
Why?
|
Fractures, Bone | 1 | 2013 | 2046 | 0.050 |
Why?
|
Accidental Falls | 1 | 2009 | 1068 | 0.050 |
Why?
|
Trauma Severity Indices | 2 | 2013 | 478 | 0.040 |
Why?
|
Receptor, Interferon alpha-beta | 2 | 2011 | 112 | 0.040 |
Why?
|
Neoplasms | 2 | 2006 | 22173 | 0.040 |
Why?
|
Gene Expression | 1 | 2013 | 7581 | 0.040 |
Why?
|
Macrophages | 3 | 2011 | 5767 | 0.040 |
Why?
|
Mice, Inbred C3H | 2 | 2011 | 915 | 0.040 |
Why?
|
Middle Aged | 8 | 2020 | 220921 | 0.040 |
Why?
|
Postoperative Period | 1 | 2023 | 1814 | 0.040 |
Why?
|
Genome, Human | 1 | 2011 | 4425 | 0.040 |
Why?
|
Mice, Transgenic | 3 | 2011 | 9542 | 0.040 |
Why?
|
Adult | 12 | 2024 | 221210 | 0.040 |
Why?
|
RNA, Messenger | 1 | 2013 | 12794 | 0.040 |
Why?
|
B-Lymphocytes | 1 | 2011 | 4758 | 0.040 |
Why?
|
Transcription, Genetic | 1 | 2011 | 7593 | 0.040 |
Why?
|
Cell Line, Tumor | 1 | 2014 | 16990 | 0.040 |
Why?
|
Gene Expression Profiling | 4 | 2014 | 9420 | 0.040 |
Why?
|
Spleen | 2 | 2013 | 2295 | 0.040 |
Why?
|
Incidence | 2 | 2013 | 21355 | 0.030 |
Why?
|
Stem Cells | 1 | 2010 | 3524 | 0.030 |
Why?
|
Predictive Value of Tests | 1 | 2013 | 15266 | 0.030 |
Why?
|
Length of Stay | 3 | 2023 | 6426 | 0.030 |
Why?
|
Young Adult | 5 | 2015 | 59260 | 0.030 |
Why?
|
Cell Division | 1 | 2003 | 4465 | 0.030 |
Why?
|
Prognosis | 4 | 2024 | 29629 | 0.030 |
Why?
|
Pancreaticojejunostomy | 1 | 1995 | 26 | 0.030 |
Why?
|
Caspases, Initiator | 1 | 2015 | 31 | 0.030 |
Why?
|
Lymphoma | 1 | 2004 | 1901 | 0.030 |
Why?
|
Critical Illness | 3 | 2012 | 2723 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2013 | 20100 | 0.030 |
Why?
|
Common Bile Duct Neoplasms | 1 | 1995 | 120 | 0.030 |
Why?
|
Risk Assessment | 2 | 2013 | 23996 | 0.030 |
Why?
|
Analysis of Variance | 2 | 2014 | 6228 | 0.030 |
Why?
|
Buttocks | 1 | 2014 | 111 | 0.030 |
Why?
|
Piperazines | 1 | 2004 | 2523 | 0.030 |
Why?
|
Immunotherapy, Adoptive | 1 | 2003 | 1469 | 0.030 |
Why?
|
Trans-Activators | 1 | 2003 | 2856 | 0.030 |
Why?
|
Hematocrit | 1 | 2015 | 623 | 0.030 |
Why?
|
Cohort Studies | 2 | 2013 | 41495 | 0.030 |
Why?
|
Peritoneum | 1 | 2014 | 225 | 0.030 |
Why?
|
Hepacivirus | 1 | 2020 | 1336 | 0.030 |
Why?
|
Pyrimidines | 1 | 2004 | 3028 | 0.030 |
Why?
|
Lymph Nodes | 1 | 2003 | 3465 | 0.020 |
Why?
|
Centrifugation, Density Gradient | 1 | 2011 | 299 | 0.020 |
Why?
|
Pancreaticoduodenectomy | 1 | 1995 | 509 | 0.020 |
Why?
|
Endotoxemia | 1 | 2013 | 196 | 0.020 |
Why?
|
Acute Disease | 2 | 2013 | 7237 | 0.020 |
Why?
|
Major Histocompatibility Complex | 1 | 2013 | 870 | 0.020 |
Why?
|
Colony Count, Microbial | 1 | 2011 | 330 | 0.020 |
Why?
|
Receptors, Chemokine | 1 | 2013 | 652 | 0.020 |
Why?
|
Mice, 129 Strain | 1 | 2011 | 371 | 0.020 |
Why?
|
Calcitonin Gene-Related Peptide | 1 | 2013 | 323 | 0.020 |
Why?
|
Receptors, Pattern Recognition | 1 | 2011 | 83 | 0.020 |
Why?
|
Immune System Diseases | 1 | 2012 | 256 | 0.020 |
Why?
|
Demography | 1 | 2015 | 1648 | 0.020 |
Why?
|
Leukocyte Count | 1 | 2014 | 1596 | 0.020 |
Why?
|
Diatrizoate Meglumine | 1 | 2009 | 79 | 0.020 |
Why?
|
GPI-Linked Proteins | 1 | 2011 | 470 | 0.020 |
Why?
|
Listeriosis | 1 | 2010 | 149 | 0.020 |
Why?
|
Disease Progression | 2 | 2024 | 13510 | 0.020 |
Why?
|
Obesity | 1 | 2012 | 12947 | 0.020 |
Why?
|
Endotoxins | 1 | 2011 | 520 | 0.020 |
Why?
|
Receptors, Interleukin-1 | 1 | 2010 | 262 | 0.020 |
Why?
|
Urinary Tract Infections | 1 | 2015 | 802 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2005 | 10194 | 0.020 |
Why?
|
Registries | 1 | 2024 | 8225 | 0.020 |
Why?
|
Long-Term Care | 1 | 2012 | 633 | 0.020 |
Why?
|
Pneumonia, Bacterial | 1 | 2010 | 317 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2020 | 3060 | 0.020 |
Why?
|
Mice, Inbred Strains | 1 | 2010 | 1762 | 0.020 |
Why?
|
Age Factors | 2 | 2014 | 18399 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2014 | 2707 | 0.020 |
Why?
|
Down-Regulation | 1 | 2013 | 2919 | 0.020 |
Why?
|
Pseudomonas Infections | 1 | 2010 | 622 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2003 | 9610 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2023 | 11530 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2014 | 1886 | 0.020 |
Why?
|
Host-Pathogen Interactions | 1 | 2014 | 1459 | 0.020 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2011 | 803 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2014 | 22176 | 0.020 |
Why?
|
Up-Regulation | 1 | 2013 | 4125 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2024 | 39106 | 0.010 |
Why?
|
Tyrphostins | 1 | 2003 | 63 | 0.010 |
Why?
|
Radiography | 2 | 2009 | 6965 | 0.010 |
Why?
|
Nitric Oxide | 1 | 2012 | 2136 | 0.010 |
Why?
|
Lymphocyte Depletion | 1 | 2005 | 602 | 0.010 |
Why?
|
Ovalbumin | 1 | 2004 | 677 | 0.010 |
Why?
|
Lipopolysaccharides | 1 | 2010 | 2206 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2015 | 4937 | 0.010 |
Why?
|
Homeodomain Proteins | 1 | 2011 | 2418 | 0.010 |
Why?
|
Hemagglutinins, Viral | 1 | 2001 | 66 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2015 | 12059 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2004 | 13642 | 0.010 |
Why?
|
RNA | 1 | 2011 | 2725 | 0.010 |
Why?
|
Birth Weight | 1 | 2009 | 2103 | 0.010 |
Why?
|
United States | 2 | 2024 | 72340 | 0.010 |
Why?
|
Staphylococcal Infections | 1 | 2010 | 1407 | 0.010 |
Why?
|
Gestational Age | 1 | 2009 | 3577 | 0.010 |
Why?
|
Hematopoiesis | 1 | 2010 | 2050 | 0.010 |
Why?
|
Bone Marrow | 1 | 2010 | 2911 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2015 | 58984 | 0.010 |
Why?
|
Proteomics | 1 | 2013 | 3848 | 0.010 |
Why?
|
STAT3 Transcription Factor | 1 | 2003 | 871 | 0.010 |
Why?
|
Benzamides | 1 | 2004 | 1371 | 0.010 |
Why?
|
Transplantation Chimera | 1 | 2001 | 594 | 0.010 |
Why?
|
Intensive Care Units | 1 | 2012 | 3744 | 0.010 |
Why?
|
Aged | 4 | 2015 | 169310 | 0.010 |
Why?
|
Genotype | 1 | 2013 | 12990 | 0.010 |
Why?
|
Clone Cells | 1 | 2001 | 1659 | 0.010 |
Why?
|
Technetium Tc 99m Sestamibi | 1 | 1998 | 174 | 0.010 |
Why?
|
Neoplasm Transplantation | 1 | 2001 | 2016 | 0.010 |
Why?
|
Pancreatic Neoplasms | 1 | 1995 | 5368 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2015 | 15843 | 0.010 |
Why?
|
Blood Pressure | 1 | 2012 | 8481 | 0.010 |
Why?
|
Tomography Scanners, X-Ray Computed | 1 | 1998 | 173 | 0.010 |
Why?
|
Risk Factors | 2 | 2015 | 74213 | 0.010 |
Why?
|
Ampulla of Vater | 1 | 1995 | 149 | 0.010 |
Why?
|
Body Mass Index | 1 | 2012 | 12953 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2001 | 6131 | 0.010 |
Why?
|
Bone Marrow Transplantation | 1 | 2001 | 2693 | 0.010 |
Why?
|
Dendritic Cells | 1 | 2004 | 2747 | 0.010 |
Why?
|
Pancreatic Ducts | 1 | 1995 | 329 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2003 | 3713 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2004 | 13446 | 0.010 |
Why?
|
Prospective Studies | 2 | 2013 | 54423 | 0.010 |
Why?
|
Peptide Fragments | 1 | 2004 | 5112 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2004 | 17635 | 0.010 |
Why?
|
Anastomosis, Surgical | 1 | 1995 | 983 | 0.010 |
Why?
|
Models, Biological | 1 | 2001 | 9469 | 0.000 |
Why?
|
Survival Rate | 1 | 1995 | 12723 | 0.000 |
Why?
|